Accessibility navigation

Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies

Imamura, F., Fretts, A. M., Marklund, M., Korat, A. V. A., Yang, W.-S., Lankinen, M., Qureshi, W., Helmer1, C., Chen1, T.-A., Virtanen, J. K., Wong, K., Bassett, J. K., Murphy, R., Tintle, N., Yu, C. I., Brouwer, I. A., Chien, K.-L., Chen, Y.-y., Wood, A. C., del Gobbo, L. C. , Djousse, L., Geleijnse, J. M., Giles, G. G., de Goede, J., Gudnason, V., Harris, W. S., Hodge, A., Hu, F., Koulman, A., Laakso, M., Lind, L., Lin, H.-J., McKnight, B., Rajaobelina, K., Riserus, U., Robinson, J. G., Samieri, C., Senn, M., Siscovick, D. S., Soedamah-Muthu, S. S., Sotoodehnia, N., Sun, Q., Tsai, M. Y., Tuomainen, T.-P., Uusitupa, M., Wagenknecht, L. E., Wareham, N. J., Wu, J. H., Micha, R., Lemaitre, R. N., Mozaffarian, D. and ForouhiI, N. G. (2020) Fatty acids in the de novo lipogenesis pathway and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies. PLoS Medicine, 17 (6). 1003102. ISSN 1549-1676

Text (Open Access) - Published Version
· Available under License Creative Commons Attribution.
· Please see our End User Agreement before downloading.


It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.1371/journal.pmed.1003102


Background De novo lipogenesis (DNL) is the primary metabolic pathway synthesizing fatty acids from carbohydrates, protein, or alcohol. Our aim was to examine associations of in vivo levels of selected fatty acids (16:0, 16:1n7, 18:0, 18:1n9) in DNL with incidence of type 2 diabetes (T2D). Methods and findings Seventeen cohorts from 12 countries (7 from Europe, 7 from the United States, 1 from Australia, 1 from Taiwan; baseline years = 1970–1973 to 2006–2010) conducted harmonized individual-level analyses of associations of DNL-related fatty acids with incident T2D. In total, we evaluated 65,225 participants (mean ages = 52.3–75.5 years; %women = 20.4%– 62.3% in 12 cohorts recruiting both sexes) and 15,383 incident cases of T2D over the 9-year follow-up on average. Cohort-specific association of each of 16:0, 16:1n7, 18:0, and 18:1n9 with incident T2D was estimated, adjusted for demographic factors, socioeconomic characteristics, alcohol, smoking, physical activity, dyslipidemia, hypertension, menopausal status, and adiposity. Cohort-specific associations were meta-analyzed with an inverse-varianceweighted approach. Each of the 4 fatty acids positively related to incident T2D. Relative risks (RRs) per cohort-specific range between midpoints of the top and bottom quintiles of fatty acid concentrations were 1.53 (1.41–1.66; p < 0.001) for 16:0, 1.40 (1.33–1.48; p < 0.001) for 16:1n-7, 1.14 (1.05–1.22; p = 0.001) for 18:0, and 1.16 (1.07–1.25; p < 0.001) for 18:1n9. Heterogeneity was seen across cohorts (I2 = 51.1%–73.1% for each fatty acid) but not explained by lipid fractions and global geographical regions. Further adjusted for triglycerides (and 16:0 when appropriate) to evaluate associations independent of overall DNL, the associations remained significant for 16:0, 16:1n7, and 18:0 but were attenuated for 18:1n9 (RR = 1.03, 95% confidence interval (CI) = 0.94–1.13). These findings had limitations in potential reverse causation and residual confounding by imprecisely measured or unmeasured factors.

Item Type:Article
Divisions:Interdisciplinary Research Centres (IDRCs) > Institute for Food, Nutrition and Health (IFNH)
ID Code:97724
Publisher:Public Library of Science


Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation